EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.20−0.26 (-10.63%)
Close on Nov 18, 2026Market cap $2.20MP/E –Yield –
EoCene shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
EoCene's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 1M, up 363.2% from the year before. Over ten years it grew 52.9% a year on average. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +363.2% |
| FY2024 | Dec 31, 2024 | 0M | +303.3% |
| FY2023 | Dec 31, 2023 | 0M | +65.2% |
| FY2022 | Dec 31, 2022 | 0M | +2.2% |
| FY2021 | Dec 31, 2021 | 0M | +15.6% |
| FY2020 | Dec 31, 2020 | 0M | +0.8% |
| FY2019 | Dec 31, 2019 | 0M | +16.4% |
| FY2018 | Dec 31, 2018 | 0M | +45.2% |
| FY2017 | Dec 31, 2017 | 0M | +9.8% |
| FY2016 | Dec 31, 2016 | 0M | +2.5% |
| FY2015 | Dec 31, 2015 | 0M | +7.5% |
| FY2014 | Dec 31, 2014 | 0M | +103.7% |
| FY2013 | Dec 31, 2013 | 0M | +2.3% |
| FY2012 | Dec 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1M | +374.0% |
| Q4 FY2025 | Dec 31, 2025 | 1M | +625.2% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +705.5% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +2719.8% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +1052.9% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +495.3% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +476.8% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +19.3% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +59.7% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +106.0% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +90.6% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +90.3% |
| Q2 FY2018 | Jun 30, 2018 | 0M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q2 FY2016 | Jun 30, 2016 | 0M | – |
| Q2 FY2015 | Jun 30, 2015 | 0M | – |
See a number that looks wrong?